Has anyone heard of MGC Pharma (ASX:MXC)?, page-10

I'll take a stab.
Assumptions:
* 20M per year to run the operation
* 25M depreciation based on half of the Pearls being up
* 1.85B shares + 60M performance shares for MM
* 30% tax rate
* No interest expenses from any debt

	Column 1	Column 2
0	Revenue	100
1	COGS, expenses etc.	20
2	EBITDA	80
3	D&A	25
4	EBIT	55
5	NPAT	38.5
6	Total shares	1910
7	EPS	0.020157
8	PE	20
9	Share price	0.403141